These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 28609775)

  • 1. Vancomycin in Very-Early Onset Inflammatory Bowel Disease-Dysbiosis: Fight Fire with Fire?
    Biedermann L
    Digestion; 2017; 95(4):327-328. PubMed ID: 28609775
    [No Abstract]   [Full Text] [Related]  

  • 2. How to Manipulate the Microbiota: Fecal Microbiota Transplantation.
    Fuentes S; de Vos WM
    Adv Exp Med Biol; 2016; 902():143-53. PubMed ID: 27161356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting friend and foe: Emerging therapeutics in the age of gut microbiome and disease.
    Cho JA; Chinnapen DJF
    J Microbiol; 2018 Mar; 56(3):183-188. PubMed ID: 29492875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota and inflammatory bowel disease: so far so gut!
    Holleran G; Lopetuso LR; Ianiro G; Pecere S; Pizzoferrato M; Petito V; Graziani C; McNAMARA D; Gasbarrini A; Scaldaferri F
    Minerva Gastroenterol Dietol; 2017 Dec; 63(4):373-384. PubMed ID: 28293937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
    Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
    J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intestinal immune response is regulated by gut microbe].
    Tanemoto S; Sujino T; Kanai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Links Between Inflammatory Bowel Disease and Chronic Obstructive Pulmonary Disease.
    Raftery AL; Tsantikos E; Harris NL; Hibbs ML
    Front Immunol; 2020; 11():2144. PubMed ID: 33042125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of fecal microbiota transplantation in the treatment of inflammatory Bowel disease.
    Khajah MA
    Scand J Gastroenterol; 2017 Nov; 52(11):1172-1184. PubMed ID: 28685630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation in Inflammatory Bowel Disease.
    Reinisch W
    Dig Dis; 2017; 35(1-2):123-126. PubMed ID: 28147375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use your antibiotics wisely. Consequences to the intestinal microbiome.
    Cervantes J
    FEMS Microbiol Lett; 2016 May; 363(10):. PubMed ID: 27044298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
    Qiao YQ; Cai CW; Ran ZH
    J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulating resident microbiota to enhance regulatory immune function to treat inflammatory bowel diseases.
    Mishima Y; Sartor RB
    J Gastroenterol; 2020 Jan; 55(1):4-14. PubMed ID: 31482438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathological and therapeutic interactions between bacteriophages, microbes and the host in inflammatory bowel disease.
    Babickova J; Gardlik R
    World J Gastroenterol; 2015 Oct; 21(40):11321-30. PubMed ID: 26525290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut Microbiota Developments With Emphasis on Inflammatory Bowel Disease: Report From the Gut Microbiota for Health World Summit 2016.
    Eppinga H; Fuhler GM; Peppelenbosch MP; Hecht GA
    Gastroenterology; 2016 Aug; 151(2):e1-4. PubMed ID: 27371370
    [No Abstract]   [Full Text] [Related]  

  • 15. Gut microbiota in the pathogenesis of inflammatory bowel disease.
    Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
    Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of the gut microbiota in the treatment of inflammatory bowel diseases.
    Aggeletopoulou I; Konstantakis C; Assimakopoulos SF; Triantos C
    Microb Pathog; 2019 Dec; 137():103774. PubMed ID: 31586663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome.
    Mizuno S; Masaoka T; Naganuma M; Kishimoto T; Kitazawa M; Kurokawa S; Nakashima M; Takeshita K; Suda W; Mimura M; Hattori M; Kanai T
    Digestion; 2017; 96(1):29-38. PubMed ID: 28628918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transplantation of a bacterial consortium ameliorates trinitrobenzenesulfonic acid-induced colitis and intestinal dysbiosis in rats.
    Li M; Li Z; Wen S; Liu Y; Wang Y; Tang L
    Future Microbiol; 2016 Jul; 11():887-902. PubMed ID: 27415182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The microbiota in inflammatory bowel disease.
    Sheehan D; Moran C; Shanahan F
    J Gastroenterol; 2015 May; 50(5):495-507. PubMed ID: 25808229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress with treating the microbial dysbiosis associated with irritable bowel syndrome.
    Pearson JS; Whorwell PJ
    Curr Opin Gastroenterol; 2017 Jan; 33(1):21-25. PubMed ID: 28134688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.